Loading...
XJPX
7061
Market cap24mUSD
Oct 09, Last price  
463.00JPY
1D
-0.22%
1Q
-21.26%
IPO
-78.62%
Name

Japan Hospice Holdings Inc

Chart & performance

D1W1MN
XJPX:7061 chart
P/E
14.07
P/S
0.28
EPS
32.90
Div yield, %
5.39%
Shrs. gr., 5y
0.99%
Rev. gr., 5y
23.57%
Revenues
14.17b
+16.95%
1,895,428,0003,015,192,0004,193,652,0004,916,896,0006,019,237,0007,894,317,0009,871,866,00012,115,000,00014,168,928,000
Net income
278m
-56.53%
-60,490,000149,456,000297,894,000107,060,000240,801,000454,729,000681,880,000639,580,000278,014,000
CFO
1.05b
+25.16%
4,667,000240,716,000322,592,000236,194,000467,099,000873,832,0001,130,463,000835,741,0001,046,031,999
Dividend
Dec 29, 202625 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Japan Hospice Holdings Inc. operates in Japan, focusing on two primary areas: hospice residential care and a range of home-based support services. Its hospice facilities offer specialized care for patients facing terminal cancer and intractable diseases. Beyond residential care, the company provides home-visit nursing and broader home care services. These home care offerings include medical assistance, physical care, and support for daily living, alongside multi-functional day and nursing care programs. The company was founded in 2017 and is headquartered in Tokyo, Japan.

Key people

Tadashi Takahashi
President, Chief Executive Officer, Representative Director · since 2024
Shinichiro Kato
Chief Financial Officer, Vice President, Director · since 2024
Satoru Arakawa
Independent Director · since 2017
Keiko Tamura
Independent Director · since 2020
Takayuki Tomida
Independent Director · since 2024
IPO date
Mar 28, 2019
Employees
778
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT